Researchers Question Credibility of Subgroup Analyses in Cancer Trials – Renal and Urology News
Subgroup analyses in cancer trials may not be credible, and their results should be interpreted with caution, according to researchers.
Subgroup analyses in cancer trials may not be credible, and their results should be interpreted with caution, according to researchers.
Early-career urologists and trainees are invited to join the Young Urologists Committee for the Young Urologists Forum, designed to address topics of special interest to…
Incorporating the chemokines in a model strongly detected clinically relevant rejections warranting biopsy and, if confirmed, antirejection treatment.
The Importance of Advocacy in Urology Guest: William F. Gee, MD Host: Micheal Darson, MD Dr. William Gee shares his expertise and experiences with Dr.…
Findings are based on a study of 88 men and 78 women with ANCA-associated vasculitis with glomerulonephritis and severe kidney disease at diagnosis.
For the first time, the AUA will offer simultaneous translation of more than 40 hours of content at AUA2024. Now, attendees can access AUA2024’s most…
Investigators will begin setting up the TRANSFORM trial in spring 2024, with study recruitment set to begin later in the year
The AUA invites the global urologic community to the 119th AUA Annual Meeting in the dynamic city of San Antonio, TX!
Irene Burger discusses the significant impact of PSMA PET in diagnosing high-risk localized prostate cancer. Dr. Burger describes the rapid adoption of this technology in…
Researchers conducted an economic evaluation to assess the sustainable cost-based prices vs market prices for insulin and antidiabetic drugs.
The 2024 AUA Annual Meeting program will offer more education and innovative programming than ever before! Join us in San Antonio.